Composition
- Active ingredients
- VIMSELTINIB 14MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- VIMSELTINIB 20MG · CapsuleNDA219304-002 · Prescription
- VIMSELTINIB 30MG · CapsuleNDA219304-003 · Prescription
- VIMSELTINIB 14MG · CapsuleThis page
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA219304.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Romvimza
- Active substance
- vimseltinib
- Route
- Oral
- Dosage form
- Capsule
- Applicant
- Deciphera Pharms
- Status
- Prescription
- FDA approval
- 14 Feb 2025
- Application
- NDA219304-001